Literature DB >> 3987540

Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients.

D L Clement, N Y De Pue.   

Abstract

The antihypertensive and vasodilator effects of felodipine, a new calcium antagonist of the dihydropyridine group, were examined in 15 patients with moderate to severe hypertension. Flow was measured simultaneously at the calf and finger using a venous occlusion ECG-triggered plethysmograph. Measurements were made at rest, during handgrip and during reactive hyperaemia. Felodipine (12.5 mg, orally) was given after placebo treatment and after 3 weeks' treatment with metoprolol. It was also given for 3 weeks in combination with metoprolol. Felodipine caused a significant decrease in blood pressure which was similar in the supine, sitting and standing positions without causing any orthostatic reaction. The antihypertensive effect was accompanied by an increase in heart rate, dilatation of calf arteries and, to a lesser degree, dilatation of finger arteries. However, the degree of vasodilatation diminished with long term treatment. Metoprolol prevented the increase in heart rate but not vasodilatation. Felodipine decreased the potential for further dilatation in certain situations, as shown during reactive hyperaemia, although vasoconstrictor responses during the handgrip test remained unimpaired.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987540     DOI: 10.2165/00003495-198500292-00024

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  8 in total

1.  Effect of selective and non-selective beta-adrenoreceptor blockade on calf blood flow in hypertensive patients.

Authors:  D L Clement
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

2.  The systemic and coronary haemodynamic effects of felodipine in patients with coronary heart disease.

Authors:  A C Tweddel; G Johnsson; T H Pringle; R G Murray; I Hutton
Journal:  Eur Heart J       Date:  1983-10       Impact factor: 29.983

Review 3.  Regulation of peripheral circulation during muscular exercise.

Authors:  D L Clement; J T Shepherd
Journal:  Prog Cardiovasc Dis       Date:  1976 Jul-Aug       Impact factor: 8.194

Review 4.  Physiological aspects of primary hypertension.

Authors:  B Folkow
Journal:  Physiol Rev       Date:  1982-04       Impact factor: 37.312

Review 5.  Circulatory changes in muscle and skin arteries in primary hypertension.

Authors:  D L Clement; D Duprez
Journal:  Hypertension       Date:  1984 Nov-Dec       Impact factor: 10.190

6.  Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension.

Authors:  D Elmfeldt; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication.

Authors:  M G Bogaert; D L Clement
Journal:  Eur Heart J       Date:  1983-03       Impact factor: 29.983

8.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  8 in total
  3 in total

Review 1.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 2.  Treatment of hypertension in patients with peripheral arterial disease: an update.

Authors:  Denis L Clement
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

Review 3.  How to treat hypertension in patients with peripheral artery disease.

Authors:  Denis L Clement; Marc L Debuyzere
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.